Compare VRSK & WAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | VRSK | WAT |
|---|---|---|
| Founded | 1971 | 1958 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Business Services | Biotechnology: Laboratory Analytical Instruments |
| Sector | Consumer Discretionary | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 29.6B | 29.3B |
| IPO Year | 2008 | 1996 |
| Metric | VRSK | WAT |
|---|---|---|
| Price | $178.37 | $301.61 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 13 | 17 |
| Target Price | $259.38 | ★ $379.19 |
| AVG Volume (30 Days) | ★ 1.9M | 825.1K |
| Earning Date | 04-29-2026 | 05-05-2026 |
| Dividend Yield | ★ 1.06% | N/A |
| EPS Growth | N/A | ★ 0.47 |
| EPS | 1.73 | ★ 10.76 |
| Revenue | N/A | ★ $3,165,286,000.00 |
| Revenue This Year | $6.68 | $104.66 |
| Revenue Next Year | $6.74 | $10.40 |
| P/E Ratio | $104.89 | ★ $28.41 |
| Revenue Growth | N/A | ★ 6.99 |
| 52 Week Low | $161.70 | $275.05 |
| 52 Week High | $322.92 | $414.15 |
| Indicator | VRSK | WAT |
|---|---|---|
| Relative Strength Index (RSI) | 46.16 | 43.69 |
| Support Level | $173.14 | $283.39 |
| Resistance Level | $184.14 | $308.16 |
| Average True Range (ATR) | 5.99 | 11.39 |
| MACD | 1.32 | -2.34 |
| Stochastic Oscillator | 37.49 | 24.54 |
Verisk is a leading data, analytics, and technology provider for property-casualty insurers. Verisk traces its history to Insurance Services Office, a nonprofit advisory organization founded in 1971 by US P&C insurers. ISO was formed as an association of insurance companies to assist with a variety of insurance use cases, such as reporting to regulators, defining policies, and determining independent premium rates. As the firm expanded its use cases, it became a for-profit company, renamed Verisk, and went public in 2009. Verisk's single segment (insurance) provides underwriting solutions, including forms, rules, loss costs, and catastrophe modeling. For claims, Verisk's solutions include property repair estimates and antifraud tools. About 83% of Verisk's revenue is US-based.
Waters sells liquid chromatography, mass spectrometry, and thermal analysis tools. These analytical instruments provide essential information on various products, such as their molecular structures and physical properties, to help clients enhance the health and well-being of end users. In early 2026, Waters merged with BD's life science and diagnostics business, which increased its concentration in diagnostics (versus none now) and discovery-related life science tools.